is-japan-changing-its-attitude-towards-generic-drugs

Will Japan be able to reduce its generic drug prices?

  • Japan
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the US. Although it records annual sales of approximately... Read more

taiwan-implemented-policies-in-2012-that-indicate-its-seriousness-towards-elevating-its-bioscience-industry

Taiwan: Fosters global partnerships

  • Taiwan
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

A small island country, Taiwan, has implemented policies that indicate its seriousness towards elevating its bioscience industry. Recently, Taiwan inaugurated biotech... Read more

south-korea-s-biotechnology-is-strengthening-its-r-d-capacity-in-genomics-proteomics-and-bioinformatics

South Korea: Strengthens position using clinical research...

  • Korea
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 1 Comment

The year 2012 has been particularly eventful for South Korea. Not only has the nation elected its first woman president, Ms Park Geun-hye, but has also made progress... Read more

in-late-2012-the-national-development-and-reform-commission-ndrc-of-china-announced-a-new-price-cut-policy-for-pharmaceuticals-effective-from-february-1-2013

China: Shines despite slower pace of growth

  • China
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

The investments pouring in China are aligned with the government's plan to boost the pharmaceutical industry of the country in its 12th Five Year Plan (2011-15),... Read more

the-debate-still-continues-where-is-india-lacking-on-the-regulatory-front

What can India do to streamline its regulatory processes?...

  • India
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

India's growing ability to innovate and provide efficient and cost-effective solutions to various bioscience problems plaguing the nation and the world, has contributed... Read more

dr-bs-bajaj-chairman-aiba-sc-and-secretary-general-federation-of-asian-biotech-associations-faba-india

FABA: We improve the global biotech place

  • India
  • |
  • Influencers
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

Federation of Asian Biotech Associations (FABA) is a professional non-profit and non-governmental society registered under the Indian Societies Act. It was established... Read more

ms-anne-trimmer-ceo-medical-technology-association-of-australia-mtaa-australia

Aus Medtech association: Reimbursements remain constrained...

  • Australia
  • |
  • Influencers
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

The Medical Technology Association of Australia (MTAA) is the national association of Australia representing companies in the medical technology industry. MTAA aims... Read more

mr-joshi-hitendra-joshi-management-consultant-at-b-braun-medical-malaysia-and-chairman-association-of-malaysian-medical-industries-ammi

AMMI chairman: We adhere to world class quality management...

  • Malaysia
  • |
  • Influencers
  • |
  • By Saptarshi Chaudhuri
  • |
  • 3 Comments

The Association of Malaysian Medical Industries (AMMI) consists of leading medical device manufacturing companies in the medical technology industry. AMMI provides... Read more

china-business-is-good

China to up healthcare spending to $1 trillion

  • China
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

Singapore: Healthcare spending in China is going to increase substantially in the comming years, according to various industry experts. The Chinese life science... Read more

mr-kevin-sheehy-general-manager-medicines-new-zealand-new-zealand

NZ funding process is opaque, lacks new medicines

  • New Zealand
  • |
  • Influencers
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

Medicines New Zealand is the industry association representing companies engaged in the research, development, manufacture and marketing of prescription medicines... Read more

ms-faye-sumner-ceo-medical-technology-industry-association-of-new-zealand-mtanz-new-zealand

Establishing joint agency with Australia has been a challenge:...

  • New Zealand
  • |
  • Influencers
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

Medical Technology Industry Association of New Zealand (MTANZ) represents manufacturers and suppliers of medical technology in New Zealand, which are used in the... Read more

thomson-medical-center-tmc-becomes-first-ever-hospital-in-singapore-to-implement-cadi-smartsense-infant-tagging-system

Cadi launches infant tagging solution

  • Singapore
  • |
  • News
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

Singapore: Thomson Medical Center (TMC) in Singapore has installed Cadi SmartSense Infant Safety Solution (Gen II), a radio frequency identification (RFID) technology... Read more

us-fiscal-cliff-what-can-the-life-science-sector-do-to-save-itself

What the US fiscal cliff means to the life sciences sector?...

  • US
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

The year 2012 has come to an end. And, although the US (and the entire planet) can breathe a sigh of relief that the Mayan predictions of the end-of-the-world did... Read more

hatchtech-cso-and-ceo-dr-vern-bowles-l-and-dr-ross-macdonald-r

Hatchtech takes on resistant head lice

  • Australia
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 1 Comment

Australia-based Hatchtech, which was started in October 2001, is developing a new generation of low-toxicity ovacides for human parasites, focussing on the human... Read more

dr-john-kurek-mentor-q-sera

Q-Sera puts snake venom to blood collection use

  • Australia
  • |
  • Influencers
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

Q-Sera is a start-up firm that has put the lethal property of coagulation present in snake venom to good commercial use. The technology behind Q-Sera involves coating... Read more

Previous 1 3

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X